Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2101043	重组抗IL-1β人源化单克隆抗体注射液	SSGJ-613	Injection	Biological Products(1)	New Drug Application	2021-04-27	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	view
CXSL2500267	重组抗IL-1β人源化单克隆抗体注射液	SSGJ-613	Injection	Biological Products(1)	New Drug Application	2025-04-07	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	view
CXSL2300773	重组抗IL-1β人源化单克隆抗体注射液	SSGJ-613	Injection	Biological Products(1)	New Drug Application	2023-11-10	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	view
CXSL2101499	重组抗IL-1β人源化单克隆抗体注射液	SSGJ-613	Injection	Biological Products(1)	New Drug Application	2021-12-22	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	view
CXSL2101042	重组抗IL-1β人源化单克隆抗体注射液	SSGJ-613	Injection	Biological Products(1)	New Drug Application	2021-04-27	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	view
CXSS2500060	重组抗IL-1β人源化单克隆抗体注射液	SSGJ-613	Injection	Biological Products(1)	New Drug Application	2025-06-06	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	view